{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:47:33Z","timestamp":1790750853697,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,3,9]],"date-time":"2017-03-09T00:00:00Z","timestamp":1489017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,3,9]],"date-time":"2017-03-09T00:00:00Z","timestamp":1489017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1038\/hr.2017.28","type":"journal-article","created":{"date-parts":[[2017,3,9]],"date-time":"2017-03-09T07:01:33Z","timestamp":1489042893000},"page":"732-737","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The differential effects of low and high doses of apelin through opioid receptors on the blood pressure of rats with renovascular hypertension"],"prefix":"10.1038","volume":"40","author":[{"given":"Mahboobeh","family":"Yeganeh-Hajahmadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Najafipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzaneh","family":"Rostamzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,9]]},"reference":[{"key":"BFhr201728_CR1","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1253\/circj.CJ-13-0702","volume":"77","author":"T Ohira","year":"2013","unstructured":"Ohira T, Iso H . Cardiovascular disease epidemiology in Asia. Circ J 2013; 77: 1646\u20131652.","journal-title":"Circ J"},{"key":"BFhr201728_CR2","unstructured":"US Department of Health and Human Services (HHS). Healthy People 2020. Available at: http:\/\/www.healthypeople.gov (last accessed 20 October 2016)."},{"key":"BFhr201728_CR3","first-page":"1","volume":"193","author":"H-C Kung","year":"2015","unstructured":"Kung H-C, Xu J . Hypertension-related mortality in the United States, 2000-2013. NCHS Data Brief 2015; 193: 1\u20138.","journal-title":"NCHS Data Brief"},{"key":"BFhr201728_CR4","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/jama.1996.03530440037034","volume":"275","author":"D Levy","year":"1996","unstructured":"Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK . The progression from hypertension to congestive heart failure. JAMA 1996; 275: 1557\u20131562.","journal-title":"JAMA"},{"key":"BFhr201728_CR5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1161\/01.HYP.37.2.371","volume":"37","author":"S Kagiyama","year":"2001","unstructured":"Kagiyama S, Varela A, PhillipsMI, Galli SM . Antisense inhibition of brain renin-angiotensin system decreased blood pressure in chronic 2-kidney 1 clip hypertensive rats. Hypertension 2001; 37: 371\u2013375.","journal-title":"Hypertension"},{"key":"BFhr201728_CR6","unstructured":"Hall JE Guyton and Hall Textbook of Medical Physiology, 13th edn. Elsevier Health Sciences: Philadelphia, PA, USA, 2015, pp 237\u2013238."},{"key":"BFhr201728_CR7","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/hr.2015.16","volume":"38","author":"RV Tiradentes","year":"2015","unstructured":"Tiradentes RV, Santuzzi CH, Clandio FRG, Mengal V, Silva NF, Neto HAF, Bissoli N, Abren GR, Gonvea SA . Combined aliskiren and l-arginine treatment reverses renovascular hypertension in an animal model. Hypertens Res 2015; 38: 471\u2013477.","journal-title":"Hypertens Res"},{"key":"BFhr201728_CR8","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/hr.2016.61","volume":"39","author":"V Mengal","year":"2016","unstructured":"Mengal V, Silva PH, Tiradentes RV, Santuzzi CH, de Almeida SA, Sena GC, Bissoli NS, Abreu GR, Gouvea SA . Aliskiren and l-arginine treatments restore depressed baroreflex sensitivity and decrease oxidative stress in renovascular hypertensive rats. Hypertens Res 2016; 39: 769\u2013776.","journal-title":"Hypertens Res"},{"key":"BFhr201728_CR9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1161\/CIRCRESAHA.110.231308","volume":"109","author":"SM DeWire","year":"2011","unstructured":"DeWire SM, Violin JD . Biased ligands for better cardiovascular drugs dissecting G-protein-coupled receptor pharmacology. Circ Res 2011; 109: 205\u2013216.","journal-title":"Circ Res"},{"key":"BFhr201728_CR10","first-page":"233","volume":"126","author":"MJ Kleinz","year":"2005","unstructured":"Kleinz MJ, Skepper JN, Davenport AP . Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells. RegulPept 2005; 126: 233\u2013240.","journal-title":"RegulPept"},{"key":"BFhr201728_CR11","first-page":"273","volume":"11","author":"AZ Kalea","year":"2010","unstructured":"Kalea AZ, Batlle D . Apelin and ACE2 in cardiovascular disease. Curr Opin Investig Drugs 2010; 11: 273\u2013282.","journal-title":"Curr Opin Investig Drugs"},{"key":"BFhr201728_CR12","doi-asserted-by":"crossref","first-page":"6090","DOI":"10.2174\/138161212803582360","volume":"18","author":"JP Headrick","year":"2012","unstructured":"Headrick JP, Pepe S, Peart JN . Non-analgesic effects of opioids: cardiovascular effects of opioids and their receptor systems. Curr Pharm Des 2012; 18: 6090\u20136100.","journal-title":"Curr Pharm Des"},{"key":"BFhr201728_CR13","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1006\/bbrc.2001.6230","volume":"290","author":"B Masri","year":"2002","unstructured":"Masri B, Lahlou H, Mazarguil H, Knibiehler B, Audigier Y . Apelin (65\u201377) activates extracellular signal-regulated kinases via a PTX-sensitive G protein. Biochem Biophys Res Commun 2002; 290: 539\u2013545.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFhr201728_CR14","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.cellsig.2011.12.012","volume":"24","author":"Y Li","year":"2012","unstructured":"Li Y, Chen J, Bai B, Du H, Liu Y, Liu H . Heterodimerization of human apelin and kappa opioid receptors: roles in signal transduction. Cell Signal 2012; 24: 991\u20131001.","journal-title":"Cell Signal"},{"key":"BFhr201728_CR15","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.peptides.2009.02.011","volume":"30","author":"N Xu","year":"2009","unstructured":"Xu N, Wang H, Fan L, Chen Q . Supraspinal administration of apelin-13 induces antinociception via the opioid receptor in mice. Peptides 2009; 30: 1153\u20131157.","journal-title":"Peptides"},{"key":"BFhr201728_CR16","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.regpep.2011.08.010","volume":"172","author":"A Soltani Hekmat","year":"2011","unstructured":"Soltani Hekmat A, Najafipour H, Nekooian AA, Esmaeli-Mahani S, Javanmardi K . Cardiovascular responses to apelin in two-kidney\u2013one-clip hypertensive rats andits receptor expression in ischemic and non-ischemic kidneys. Regul Pept 2011; 172: 62\u201368.","journal-title":"Regul Pept"},{"key":"BFhr201728_CR17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.regpep.2012.06.006","volume":"178","author":"H Najafipour","year":"2012","unstructured":"Najafipour H, Hekmat AS, Nekooian AA, Esmaeili-Mahani S . Apelin receptor expression in ischemic and non-ischemic kidneys and cardiovascular responsesto apelin in chronic two\u2010kidney\u2013one\u2010clip hypertension in rats. Regul Pept 2012; 178: 43\u201350.","journal-title":"Regul Pept"},{"key":"BFhr201728_CR18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s13105-015-0394-z","volume":"71","author":"H Najafipour","year":"2015","unstructured":"Najafipour H, Vakili A, Shahouzehi B, Hekmat AS, Masoomi Y, Yeganeh Hajahmadi M, Esmaeli-Mahani S . Investigation of changes in apelin receptor mRNA and protein expression in the myocardium and aorta of rats with two-kidney, one-clip (2K1C) Goldblatt hypertension. J Physiol Biochem 2015; 71: 165\u2013175.","journal-title":"J Physiol Biochem"},{"key":"BFhr201728_CR19","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0006-8993(80)90800-8","volume":"184","author":"N Zamir","year":"1980","unstructured":"Zamir N, Simantov R, Segal M . Pain sensitivity and opioid activity in genetically and experimentally hypertensive rats. Brain Res 1980; 184: 299\u2013310.","journal-title":"Brain Res"},{"key":"BFhr201728_CR20","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1161\/01.HYP.17.5.707","volume":"17","author":"M Martinez-Maldonado","year":"1991","unstructured":"Martinez-Maldonado M . Pathophysiology of renovascular hypertension. Hypertension 1991; 17: 707\u2013719.","journal-title":"Hypertension"},{"key":"BFhr201728_CR21","first-page":"H2201","volume":"298","author":"GJ Gross","year":"2010","unstructured":"Gross GJ, Baker JE, Hsu A, Wu H-e, Falck JR, Nithipatikom K . Evidence for a role of opioids in epoxyeicosatrienoic acid-induced cardioprotection in rat hearts. Am J Physiol 2010; 298: H2201\u2013H2207.","journal-title":"Am J Physiol"},{"key":"BFhr201728_CR22","first-page":"H1229","volume":"276","author":"RM Fryer","year":"1999","unstructured":"Fryer RM, Schultz JEJ, Hsu AK, Gross GJ . Importance of PKC and tyrosine kinase in single or multiple cycles of preconditioning in rat hearts. Am J Physiol 1999; 276: H1229\u2013H1235.","journal-title":"Am J Physiol"},{"key":"BFhr201728_CR23","first-page":"H495","volume":"275","author":"JEJ Schultz","year":"1998","unstructured":"Schultz JEJ, Hsu AK, Barbieri JT, Li P-L, Gross GJ . Pertussis toxin abolishes the cardioprotective effect of ischemic preconditioning in intact rat heart. Am J Physiol 1998; 275: H495\u2013H500.","journal-title":"Am J Physiol"},{"key":"BFhr201728_CR24","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/01.RES.0000033522.37861.69","volume":"91","author":"I Szokodi","year":"2002","unstructured":"Szokodi I, Tavi P, F\u00f6ldes G, Voutilainen-Myllyl\u00e4 S, Ilves M, Tokola H, Pikkarainen S, Piuhola J, Rys\u00e4 J, T\u00f3th M . Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ Res 2002; 91: 434\u2013440.","journal-title":"Circ Res"},{"key":"BFhr201728_CR25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0167-0115(01)00236-1","volume":"99","author":"K Tatemoto","year":"2001","unstructured":"Tatemoto K, Takayama K, Zou M-X, Kumaki I, Zhang W, Kumano K, Fujimiya M . The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul Pept 2001; 99: 87\u201392.","journal-title":"Regul Pept"},{"key":"BFhr201728_CR26","first-page":"26274","volume":"279","author":"J Ishida","year":"2004","unstructured":"Ishida J, Hashimoto T, Hashimoto Y, Nishiwaki S, Iguchi T, Harada S, Sugaya T, Matsuzaki H, Yamamoto R, Shiota N . Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo. J BiolChem 2004; 279: 26274\u201326279.","journal-title":"J BiolChem"},{"key":"BFhr201728_CR27","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.cardiores.2007.02.002","volume":"74","author":"J-C Zhong","year":"2007","unstructured":"Zhong J-C, Yu X-Y, Huang Y, Yung L-M, Lau C-W, Lin S-G . Apelin modulates aortic vascular tone via endothelial nitric oxide synthase phosphorylation pathway in diabetic mice. Cardiovasc Res 2007; 74: 388\u2013395.","journal-title":"Cardiovasc Res"},{"key":"BFhr201728_CR28","doi-asserted-by":"crossref","unstructured":"Pappano AJ, Wier G Cardiovascular Physiology, 10th edn, Chapter 7. \u201cThe arterial system\u201d. Mosby: St Louis, CO, Philadelphia, PA, USA, 2013, pp 135\u2013151.","DOI":"10.1016\/B978-0-323-08697-4.00007-1"},{"key":"BFhr201728_CR29","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1210\/en.2004-0359","volume":"146","author":"DK Lee","year":"2005","unstructured":"Lee DK, Saldivia VR, Nguyen T, Cheng R, George SR, O\u2019Dowd BF . Modification of the terminal residue of apelin-13 antagonizes its hypotensive action. Endocrinology 2005; 146: 231\u2013236.","journal-title":"Endocrinology"},{"key":"BFhr201728_CR30","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0143-4179(85)90088-5","volume":"5","author":"F-y Sun","year":"1985","unstructured":"Sun F-y, Zhang A-z . Dynorphin receptor in the blood vessel. Neuropeptides 1985; 5: 595\u2013598.","journal-title":"Neuropeptides"},{"key":"BFhr201728_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gb-2002-3-11-research0063","volume":"3","author":"P Joost","year":"2002","unstructured":"Joost P, Methner A . Phylogenetic analysis of 277 human G-protein-coupled receptors as a tool for the prediction of orphan receptor ligands. Genome Biol 2002; 3: 1\u201316.","journal-title":"Genome Biol"},{"key":"BFhr201728_CR32","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/aps.2011.173","volume":"33","author":"R Zhang","year":"2012","unstructured":"Zhang R, Xie X . Tools for GPCR drug discovery. Acta Pharmacol Sin 2012; 33: 372\u2013384.","journal-title":"Acta Pharmacol Sin"},{"key":"BFhr201728_CR33","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1089\/ars.2010.3454","volume":"15","author":"T Duparc","year":"2011","unstructured":"Duparc T, Colom A, Cani PD, Massaly N, Rastrelli S, Drougard A, Le Gonidec S, Moul\u00e9dous L, Frances B, Leclercq I . Central apelin controls glucose homeostasis via a nitric oxide-dependent pathway in mice. Antioxid Redox Signaling 2011; 15: 1477\u20131496.","journal-title":"Antioxid Redox Signaling"},{"key":"BFhr201728_CR34","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.yjmcc.2005.07.007","volume":"39","author":"H Shimokawa","year":"2005","unstructured":"Shimokawa H, Morikawa K . Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in animals and humans. J Mol Cell Cardiol 2005; 39: 725\u2013732.","journal-title":"J Mol Cell Cardiol"},{"key":"BFhr201728_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10799899609039938","volume":"16","author":"MD Pak","year":"1996","unstructured":"Pak MD, Fishman PH . Anomalous behavior of CGP 12177A ON \u03b22-adrenergic receptors. J Recept Signal Transd 1996; 16: 1\u201323.","journal-title":"J Recept Signal Transd"},{"key":"BFhr201728_CR36","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.tips.2007.06.011","volume":"28","author":"JG Baker","year":"2007","unstructured":"Baker JG, Hill SJ . Multiple GPCR conformations and signalling pathways: implications for antagonist affinity estimates. Trends Pharmacol Sci 2007; 28: 374\u2013381.","journal-title":"Trends Pharmacol Sci"},{"key":"BFhr201728_CR37","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0022-3565(24)39154-2","volume":"294","author":"AA Konkar","year":"2000","unstructured":"Konkar AA, Zhu Z, Granneman JG . Aryloxypropanolamine and catecholamine ligand interactions with the \u03b21-adrenergic receptor: evidence for interaction with distinct conformations of \u03b21-adrenergic receptors. J Pharmacol ExpTher 2000; 294: 923\u2013932.","journal-title":"J Pharmacol ExpTher"},{"key":"BFhr201728_CR38","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/21441","volume":"399","author":"BA Jordan","year":"1999","unstructured":"Jordan BA, Devi LA . G-protein-coupled receptor heterodimerization modulates receptor function. Nature 1999; 399: 697\u2013700.","journal-title":"Nature"},{"key":"BFhr201728_CR39","first-page":"343","volume":"98","author":"B Jordan","year":"2001","unstructured":"Jordan B, Trapaidze N, Gomes I, Nivarthi R, Devi L . Oligomerization of opioid receptors with \u03b22-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. Proc Natl Acad Sci USA 2001; 98: 343\u2013348.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/hr201728","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/hr201728.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/hr.2017.28","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/hr201728.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T11:21:12Z","timestamp":1750072872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/hr201728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,9]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["BFhr201728"],"URL":"https:\/\/doi.org\/10.1038\/hr.2017.28","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,9]]},"assertion":[{"value":"4 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}